Replies to post #55182 on Biotech Values

[walldiver]

Turnaround stocks: ACHN, ADLR, AEZS, CGPI, CEGE, CVTX, ENCY, FVRL, IDIX, INSM, JAV, NABI, OPXA, PANC, PCYC, SCLN, and YMI.

I included revenue generators CGPI, CVTX, ENCY, and IDIX since you included VPHM, so I assume they're eligible. I didn't include DSCO because it's not down appreciably from January, but I think it could be considered a turnaround candidate because it's been down for a lot longer than one year, and has a shot at taking off if the FDA finally approves Surfaxin in Q1 2008. If you agree, then we can add DSCO to the above list.

[icebrg]

COR, CRIS, KOSN

[ghmm]

Seems there are no shortage of candidates. Here a few more that I don't believe have been posted:

crgn, acm.l (ACAMF.PK), epix, npsp, DDS.TO (DDSS), fvrl, sppi, plx

Until the past week dcth and ziop

[dewophile]

JAV,RPRX

[medchal]

UGNE is a possibility.

[surf1944]

Here is one that is trading near cash, the fund companies are increasing their positions, insiders are buying and has yet to be listed:

OLGC

[lumpy9200]

Turnaround for 2008

If (I know, big if) Provenge is stat sig at the interim look, DNDN will finish 2008 MUCH higher than where it appears it will start the year. If we can deviate to some of the small medical device companies we mention here, than I would add CAMH and RPBIF as additional choices for possible large turnarounds.

Best regards,
Geoff

[nuere]

I sure hope OXGN will turnaround. It's been a frustrating year..